CDKN2D and posterior cortical atrophy: MALAT1 acts as a transcriptional and epigenetic regulator [149], while CRNDE modulates cell proliferation and angiogenesis via the miR-451a/CDKN2D axis in PCa, representing a possible therapeutic target for PCa treatment [150].